• >
  • >
  • >
  • >
  • >
Upload Avatar (500 x 500)
Xiaofei Li
Life Science
Shanghai Jiao Tong University
Shanghai
Language: English, Chinese
Contact
Chronic Inflammation Pathogenesis Resolution Mechanisms Comorbidities Treatment Strategies Hematopoietic Stem Cells Trained Immunity Epigenetic Regulation Immune Cells Tissue Homeostasis
Areas of Focus
  • Pathogenesis and resolution mechanisms of chronic inflammation
  • Pathogenesis and treatment strategies of chronic comorbidities
  • Epigenetic regulation mechanisms in trained immunity of hematopoietic stem cells
Work Experience
  • 2022-present: Associate Professor, School of Life Sciences and Technology, Shanghai Jiao Tong University
  • 2015-2021: Postdoctoral Researcher, Department of Translational Medicine, University of Pennsylvania
Academic Background & Achievements
  • 2010-2015: PhD in Pathogen Biology, Fudan University
  • 2006-2010: Bachelor of Science in Biological Sciences, Henan University
Publications
  • Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities, Xiaofei Li et al., 2022
  • DEL-1 promotes macrophage efferocytosis and clearance of inflammation, Xiaofei Li et al., 2019
  • The DEL-1/β3 integrin axis promotes regulatory T cell responses during inflammation resolution, Xiaofei Li et al., 2020
  • Immunometabolic control of hematopoiesis, Xiaofei Li et al., 2021
  • Innate immune training of granulopoiesis promotes anti-tumor activity, Xiaofei Li et al., 2020
  • Stromal cell–derived DEL-1 inhibits Tfh cell activation and inflammatory arthritis, Xiaofei Li et al., 2021
  • The secreted protein DEL-1 activates a β3 integrin–FAK–ERK1/2–RUNX2 pathway and promotes osteogenic differentiation and bone regeneration, Xiaofei Li et al., 2020
Post a Project

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that AGP may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from AGP.
Submit

Thank you for your message!
We will contact you soon.